Astec LifeSciences (India) Today
| ASTEC Stock | 726.50 39.85 5.20% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Astec LifeSciences is selling at 726.50 as of the 2nd of March 2025; that is 5.2 percent decrease since the beginning of the trading day. The stock's open price was 766.35. Astec LifeSciences has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 31st of January 2025 and ending today, the 2nd of March 2025. Click here to learn more.
Business Domain Materials | Category Basic Materials |
Astec LifeSciences is entity of India. It is traded as Stock on NSE exchange. The company has 19.61 M outstanding shares. More on Astec LifeSciences Limited
Moving together with Astec Stock
| 0.72 | EMBASSY-RR | Embassy Office Parks | PairCorr |
| 0.76 | JAIBALAJI | Jai Balaji Industries Split | PairCorr |
| 0.7 | GUJALKALI | Gujarat Alkalies | PairCorr |
Moving against Astec Stock
| 0.74 | UNIVAFOODS | Univa Foods Limited | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Astec Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Astec LifeSciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Astec LifeSciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Anurag Roy | ||||
| Business Concentration | Fertilizers & Agricultural Chemicals, Agricultural Inputs, Basic Materials, Materials, Chemicals, Agricultural Inputs, Basic Materials (View all Sectors) | ||||
Astec LifeSciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Astec LifeSciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAstec LifeSciences can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Astec LifeSciences' financial leverage. It provides some insight into what part of Astec LifeSciences' total assets is financed by creditors.
| |||||
Astec LifeSciences Limited (ASTEC) is traded on National Stock Exchange of India in India and employs 606 people. Astec LifeSciences is listed under Fertilizers & Agricultural Chemicals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 14.25 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Astec LifeSciences's market, we take the total number of its shares issued and multiply it by Astec LifeSciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Astec LifeSciences operates under Chemicals sector and is part of Materials industry. The entity has 19.61 M outstanding shares.
Astec LifeSciences Limited has accumulated about 16.84 M in cash with 102.21 M of positive cash flow from operations.
Check Astec LifeSciences Probability Of Bankruptcy
Ownership AllocationAstec LifeSciences holds a total of 19.61 Million outstanding shares. Astec LifeSciences Limited shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.56 percent of Astec LifeSciences outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Astec Ownership Details
Astec LifeSciences Risk Profiles
Although Astec LifeSciences' alpha and beta are two of the key measurements used to evaluate Astec LifeSciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.43 | |||
| Standard Deviation | 4.05 | |||
| Variance | 16.39 | |||
| Risk Adjusted Performance | (0.08) |
Astec Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Astec LifeSciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Astec LifeSciences Corporate Management
Elected by the shareholders, the Astec LifeSciences' board of directors comprises two types of representatives: Astec LifeSciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Astec. The board's role is to monitor Astec LifeSciences' management team and ensure that shareholders' interests are well served. Astec LifeSciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Astec LifeSciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kirubasekaran | Vice Marketing | Profile | |
| Tarun Surya | GM sales | Profile | |
| Vivek Verma | GM Operations | Profile | |
| Madhur Gundecha | Chief Officer | Profile | |
| Mugdha Khare | Chief Officer | Profile | |
| K Rao | Technical Consultant | Profile |
Other Information on Investing in Astec Stock
Astec LifeSciences financial ratios help investors to determine whether Astec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Astec with respect to the benefits of owning Astec LifeSciences security.